Long-term gallbladder stone recurrence and risk factors after successful lithotripsy

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 2, 2000, Pages 209-215

  Carrilho Ribeiro, Luís ^a,b   Pinto Correia, António ^a   Velosa, José ^a   Carneiro de Moura, Miguel ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b Hospital Garcia Orta   (Portugal)

Author keywords

Gallstone recurrence; Gallstones; Shock wave lithotripsy

Indexed keywords

URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CHOLELITHIASIS; CONSERVATIVE TREATMENT; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LITHOTRIPSY; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RECURRENT DISEASE; REGRESSION ANALYSIS; RISK; RISK FACTOR;

EID: 0034105984     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012020-00013     Document Type: Article

References (37)

1. 1 O'Donnell LDJ, Heaton KW. Recurrence and re-recurrence of gallstones after medical dissolution: a long-term follow-up. Gut 1988; 29:655-658.
2. 2 Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzela G, Festi D, et al. Gallstone recurrence after successful oral bile acid treatment. Gastroenterology 1989; 97:726-731.
3. 3 Petroni ML, Jazrawi RP, Coggin PM, Lanzini A, Facchinetti D, Heaton K, et al. Characteristics of recurrent gallstones following non-surgical treatment: implications for retreatment. Eur J Gastroenterol Hepatol 1991; 3:473-478.
4. 4 Sackmann M, Niller H, Klueppelberg U, von Ritter C, Pauletzki J, Holl J, et al. Gallstone recurrence after shock-wave therapy. Gastroenterology 1994; 106:225-230.
5. 5 Pelletier G, Raymond JM, Capdeville R, Mosnier H, Caroli-Bosc FX. Gallstone recurrence after successful lithotripsy. J Hepatol 1995; 23:420-423.
6. 6 Pinto-Correia A, Carrilho-Ribeiro L, Contente LF, Carneiro de Moura M. A litotricia extra-corporal por ondas de choque no tratamento da litiase vesicular: os primeiros 109 doentes. Acta Médica Portuguesa 1993; 6:307-310.
7. 7 Carrilho-Ribeiro L, Pinto-Correia A, Contente LF, Carneiro de Moura M. An aggressive protocol of ESWL and dissolution therapy of gallbladder stones. Hepato-Gastroenterology 1995; 42:259-264.
8. 8 Paumgartner G, Carr-Locke DL, Dubois F, Roda E, Thistle JL. Strategies in the treatment of gallstone disease. Gastroenterol Int 1993; 6:65-75.
9. 9 Elston RC, Johnson WD. Essentials of Biostatistics. Philadelphia: FA Davis Company; 1987.
10. 10 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JASA 1958; 53:457-481.
11. 11 Kalbfleisch JD, Prentice RL.The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons; 1980.
12. 12 Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34:187-220.
13. 13 Garrow JS. Treat Obesity Seriously. Edinburgh: Churchill-Livingstone; 1981.
14. 14 Adamek HE, Sorg S, Bachor A, Riemann JF. Symptoms of post-extracorporeal shock wave lithotripsy: long-term analysis of gallstone patients before and after successful shock wave lithotripsy. Am J Gastroenterol 1995; 90:1125-1129.
15. 15 Wehrmann T, Marek S, Hanisch E, Lembcke B, Caspary WF. Causes and management of recurrent biliary pain after successful nonoperative gallstone treatment. Am J Gastroenterol 1997; 92:132-138.
16. 16 Jazrawi RP. Gallstone recurrence and its management. Eur J Gastroenterol Hepatol 1994; 6:880-884.
17. 17 Schneider HT, Benninger J, Rabes U, Madani N, May A, Hahn EG, et al. Recurrent gallstone formation after extracorporeal shock-wave lithotripsy. Am J Gastroenterol 1993; 88:1399-1404.
18. 18 Portincasa P, van Erpecum KJ, van de Meeberg PC, Dallinga-Thie GM, de Bruin TWA, van Berge-Henegouwen GP. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy. Hepatology 1996; 24:580-587.
19. 19 Pauletzki J, Althaus R, Holl J, Sackmann M, Paumgartner G. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology 1996; 111:765-771.
20. 20 Petroni ML, Jazrawi RP, Lanzini A, Zuin M, Pazzi P, Fracchia M, et al. Repeated bile acid therapy for the long-term management of cholesterol gallstones. J Hepatol 1996; 25:719-724.
21. 21 Groen AK, Noordam C, Drapers JAG, Egbers P, Jansen PLM, Tytgat GNJ. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease. Hepatology 1990; 11:525-533.
22. 22 Jungst D, Lang T, von Ritter C, Pratschke E, Paumgartner G. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones. Hepatology 1992; 15:804-808.
23. 23 Tudyka J, Kratzer W, Kuhn K, Mason R, Weschler JG, Adler G. Solitary versus multiple gallstones: the importance of total biliary protein concentration and other factors. Hepato-Gastroenterology 1995; 42:638-644.
24. 24 Ruppin DC, Dowling RH. Is recurrence inevitable after gallstone dissolution by bile-acid treatment? Lancer 1982; i:181-184.
25. 25 Hood KA, Gleeson D, Ruppin DC, Dowling RH. Gall stone recurrence and its prevention: the British/Belgian gall stone study group's post-dissolution trial. Gut 1993; 34:1277-1288.
26. 26 Attili AF, Capocaccia N, Carulli D, Festi D, Roda E, Barbara L, et al. Factors associated with gallstone disease in the MICOL experience. Hepatology 1997; 26:809-818.
27. 27 Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease: the effect of cholecystectomy and obesity. J Clin Invest 1977; 59:828-840.
28. 28 Pattinson NR, Chapman BA. Distribution of biliary cholesterol between mixed micelles and nonmicelles in relation to fasting and feeding in humans. Gastroenterology 1986; 91:697-702.
29. 29 Marks JW, Bonorris GG, Schoenfield LJ. Effects of AUDC or ibuprofen on contraction of gallbladder and bile among obese patients during weight loss. Dig Dis Sci 1996; 41:242-249.
30. 30 Berr F, Mayer M, Sackmann MF, Sauerbruch T, Holl J, Paumgartner G. Pathogenic factors in early recurrence of cholesterol gallstones. Gastroenterology 1994; 106:215-224.
31. 31 Pereira SP, Hussaini SH, Kennedy C, Dowling RH. Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type? Dig Dis Sci 1995; 40:2568-2575.
32. 32 Bell GD, Dowling RH, Whitney B, Sutor DJ. The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut 1975; 16:359-364.
33. 33 Mok HYI, Druffel ERM, Rampone WM. Chronology of cholelithiasis: dating gallstones from atmospheric radiocarbon produced by nuclear bomb explosions. N Engl J Med 1986; 314:1075-1077.
34. 34 Bazzoli F, Festi D, Mazzella G, Frabboni R, Zagari RM, Fossi S, et al. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxycholic, ursodeoxycholic and tauroursodeoxycholic acids. Am J Gastroenterology 1995; 90:978-981.
35. 35 Marks JW, Lan S, the Steering Committee and the National Cooperative Gallstone Study Group. Low dose chenodiol to prevent gallstone recurrence after dissolution therapy. Ann Intern Med 1984; 100:376-381.
36. 36 Tudyka J, Wechsler JG, Kratzer W, Maier C, Mason R, Kuhn K, et al. Gallstone recurrence after successful dissolution therapy. Dig Dis Sci 1996; 41:235-241.
37. 37 Adamek HE, Buttmann A, Weber J, Riemann JF. Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy? Scand J Gastroenterol 1994; 29:355-359.